EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prevalence and molecular characteristics of ceftazidime-avibactam resistance among carbapenem-resistant Pseudomonas aeruginosa clinical isolates

Yili Chen, Guoxiu Xiang, Pingjuan Liu, Xianling Zhou, Penghao Guo, Zhongwen Wu, Juhua Yang, Peisong Chen, Junqi Huang, Kang Liao

Journal of Global Antimicrobial Resistance · 2024

DOI: 10.1016/j.jgar.2024.01.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Global Antimicrobial Resistance, 2024. Verfasst von Yili Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Pseudomonas Infections, Ceftazidime, Azabicyclo Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Resistance against ceftazidime-avibactam (CZA) in carbapenem-resistant Pseudomonas aeruginosa (CRPA) is emerging. This study was aimed at detecting the prevalence and molecular characteristics of CZA-resistant CRPA clinical isolates in Guangdong Province, China. METHODS: The antimicrobial susceptibility profile of these strains was determined. A subset of 16 CZA-resistant CRPA isolates was analysed by whole-genome sequencing (WGS). Genetic surroundings of carbapenem resistance genes and pan-genome-wide association analysis were further studied. RESULTS: Of the 250 CRPA isolates, CZA resistance rate was 6.4% (16/250). The minimum inhibitory concentration (MIC) of CZA range was from 0.25 to >256 mg/L. MIC50 and MIC90 were 2/4 and 8/4 mg/L, respectively. Among the 16 CZA-resistant CRPA strains, 31.3% (5/16) of them carried class B carbapenem resistance genes, including blaIMP-4, blaIMP-45, and blaVIM-2, located on IncP-2 megaplasmids or chromosomes, respectively. Pan-genome-wide association analysis of accessory genes for CZA-susceptible or -resistant CRPA isolates showed that PA1874, a hypothetical protein containing BapA prefix-like domain, was enriched in CZA-resistant group significantly. CONCLUSIONS: Class B carbapenem resistance genes play important roles in CZA resistance. Meanwhile, the PA1874 gene may be a novel mechanism involving in CZA resistance. It is necessary to continually monitor CZA-resistant CRPA isolates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsPseudomonas InfectionsCeftazidimeAzabicyclo CompoundsHumansPseudomonas aeruginosaPrevalenceGenome-Wide Association StudyCarbapenemsDrug Combinations

Stichwörter der Autor:innen

Carbapenem-resistant Pseudomonas aeruginosaCeftazidime-avibactam resistanceWhole-genome sequencing

Substanzen

avibactam, ceftazidime drug combinationAnti-Bacterial AgentsCarbapenemsCeftazidimeDrug CombinationsAzabicyclo Compounds

Autor:innen und Institutionen

  • Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Department of Laboratory Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • KingMed School of Laboratory Medicine, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Vision Medicals Co., Ltd, Guangzhou, China.
  • Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; Organ Transplant Centre, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China; Guangdong…
  • Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. Electronic address: liaokang8461@163.com.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Chen, Y., Xiang, G., Liu, P., Zhou, X., Guo, P., Wu, Z., Yang, J., Chen, P., Huang, J., & Liao, K. (2024). Prevalence and molecular characteristics of ceftazidime-avibactam resistance among carbapenem-resistant Pseudomonas aeruginosa clinical isolates. Journal of Global Antimicrobial Resistance. https://doi.org/10.1016/j.jgar.2024.01.014

Vancouver

Chen Y, Xiang G, Liu P, Zhou X, Guo P, Wu Z, et al. Prevalence and molecular characteristics of ceftazidime-avibactam resistance among carbapenem-resistant Pseudomonas aeruginosa clinical isolates. Journal of Global Antimicrobial Resistance. 2024. doi:10.1016/j.jgar.2024.01.014

BibTeX
@article{Chen2024,
  author = {Chen, Yili and Xiang, Guoxiu and Liu, Pingjuan and Zhou, Xianling and Guo, Penghao and Wu, Zhongwen and Yang, Juhua and Chen, Peisong and Huang, Junqi and Liao, Kang},
  title = {Prevalence and molecular characteristics of ceftazidime-avibactam resistance among carbapenem-resistant Pseudomonas aeruginosa clinical isolates},
  journal = {Journal of Global Antimicrobial Resistance},
  year = {2024},
  doi = {10.1016/j.jgar.2024.01.014}
}
Kostenlos starten →